Terms ending in 2039
Every in-force patent on Bicycletx Limited's record whose computed term ends in 2039, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 10,875,894 | Multimeric Bicyclic Peptide Ligands In force · High confidence | Bicycletx Limited | In force | High confidence | |
| US 11,542,304 | Multimeric Bicyclic Peptide Ligands In force · High confidence | Bicycletx Limited | In force | High confidence | |
| US 12,378,288 | Multimeric Bicyclic Peptide Ligands In force · High confidence | Bicycletx Limited | In force | High confidence | |
| US 11,453,703 | Heterotandem Bicyclic Peptide Complexes In force · High confidence | Bicycletx Limited | In force | High confidence | |
| US 11,180,531 | Bicyclic Peptide Ligands Specific for NECTIN-4 In force · High confidence | Bicycletx Limited | In force | High confidence | |
| US 11,453,702 | Bicyclic Peptide Ligands Specific for NECTIN-4 In force · High confidence | Bicycletx Limited | In force | High confidence | |
| US 11,912,792 | Bicyclic Peptide Ligands Specific for NECTIN-4 In force · High confidence | Bicycletx Limited | In force | High confidence | |
| US 12,459,974 | Bicyclic Peptide Ligands Specific for NECTIN-4 In force · Medium confidence | Bicycletx Limited | In force | Medium confidence | |
| US 10,919,937 | Bicyclic Peptide Ligands and Uses Thereof In force · High confidence | Bicycletx Limited | In force | High confidence | |
| US 11,396,530 | Bicyclic Peptide Ligands and Uses Thereof In force · High confidence | Bicycletx Limited | In force | High confidence |
10 of 10 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.